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THE ROLE OF PROTEOLYTIC ENZYMES IN THE
PRODUCTION OF PRURITUS IN MAN*t
ROBERT P. ARTHUR, M.D. AND WALTER B. SHELLEY, M.D., PH.D.
Although the chemistry and pharmacology of synaptic neural transmission has
received much attention, little study has been devoted to the nature of chemical
excitation of sensory nerve receptors. The technical difficulties have been great.
The employment of animal subjects precludes accurate assessment of sensory
reception, and electronic recordings from peripheral nerve fibers cannot be
achieved easily. The most satisfactory approach at present is to study the chemi-
cal excitation of sensation in man's skin. Here, the recording of sensory findings is
qualitatively accurate, direct, and simple, and a wide range of compounds may be
readily introduced into tue region of the sensory nerve receptors (1).
Our recent studies with cowhage demonstrated for the first time that a proteo-
lytic enzyme plays a role in cutaneous sensation and embarked us on the present
investigation of enzymes in the general problem of sensation (2). This report
describes the experimental production of pruritus by a variety of endopeptidases
of both animal and vegetable sources.
1tETHODS
The normal skin of the ventral surface of the forearm of healthy adult male
subjects was used as a test site. Three methods of administration were employed:
(1) Intradermal injection, as superficial as possible, of 0.02 ml. of various
dilutions of a freshly prepared 0.9 % aqueous sodium chloride solution of the test
enzyme. A number 30 hypodermic needle was employed so that minimal or no
pain was experienced upon the introduction of the needle. All of the enzymes
were screened by this method, using a concentration of 1/1000.
(2) Introduction of 0.10 ml. of various dilutions of freshly prepared enzymes in
0.9 % saline solution into evacuated cantharidin vesicles produced by the appli-
cation of the following cantharidin ointment, 12 to 24 hours previously:
Cantharidin 0.2 gm.
Acetone 10.0
Castor oil 20.0
Beeswax 40.0
Wool fat 39.8
(3) Introduction of a single cowhage spicule impregnated by soaking in a 10_i
to 10 enzyme solution, after initial heat inactivation of the endogenous mucu-
nain in the spicule. The air-dried spicule was then introduced into the skin using
* From the Department of Dermatology (Dr. Donald M. Pillsbury, Director), Univer-
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f Preliminary note published in Nature, 175: 901, 1955.
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forceps and 30 X magnification. This method permitted the injection of micro-
quantities into the epidermis with minimal effects on the underlying dermis.
Records were kept of the subjects' verbal description of the sensations ex-
perienced, and timing relations were noted to the nearest second. Single tests
were done at any given time, since sensory changes at one site commonly sup-
pressed those elsewhere. Any given cantharidin vesicle was used but once.
Application of test solutions to scratches, or areas from which the epidermis
had been removed by scotch tape strippings proved to be valueless, since these
sites were at least initially insensitive. The cantharidin bulla technic (1) in
which the blister base is debrided and used repeatedly did not prove satisfactory
for us, since these test areas frequently became hyperalgesic.
Room temperature was kept relatively constant at about 21—22°C. Normal
young healthy male adults served as subjects. They devoted their attention
carefully to the test and other interfering sensory stimuli were kept at a minimum.
They were not instructed as to the nature of any of the test solutions or the
responses that might be expected. All of the preparations were tested on at least
4 subjects, and papain was tested on 75 subjects.
The following enzyme preparations were employed (The numbers refer to the
commercial source given in footnote):
Acid phosphatase (1) Hexokinase (4)
Alkaline phosphatase (7) Invertase (4)
Amylase alpha (1, 4) Lactase (4)
Amylase beta (4, 1*) Lipase (4)
D amino oxidase (7) Maltase (1, 4)
Amino peptidase (leucine) Mucunainb
Arginase (7) Pancreatin (2)
Bromelaine (2) Papain (2,** 7**)
Carbonic anhydrase (7) Peroxidase (1)
Carboxypeptidase (7***) Pepsin (3, 7**)
Carnosinase (7) Pectinase (4)
Catalase (1) Phosphorylase (potato) (1)
Chymotrypsin (l,* 2,* 4,* 7*) Plasmine
Cocarboxylase (5) Plasminogen"
Coenzyme A (4) Proteinase, bacterial origin"
Cozymase (5) Proteinase, fungal origin (1, 4)
Dehydrogenase, glucose 6 phosphate (6) Proteinase, pancreatic (2, 7)
Desoxyribonuclease (7*) Rennen (2)
Emulsin (4) Ribonuclease (7*)
Ficin (2) Streptokinase-Streptodornase°
Galactosidase, beta (1) Tyrosinase (1)
Glucosidase, beta (1) Trypsin (7**)
Glucuronidase, beta (4, 6, 7) Urease (4)
Hemicellulose (4) Unease (4)
The enzymes were purchased from the following sources:
(1) Bios Laboratories, New York City.
(2) General Biochemicals, Inc., Chagrin Falls, Ohio.
(3) Merck, Rahway, New Jersey.
(4) Nutritional Biochem. Corp., Cleveland, Ohio.
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(5) Schwarz Lab., Mount Vernon, New York.
(6) Sigma, St. Louis, Missouri.
(7) Worthington Biochem. Corp., Freehold, New Jersey.
* Crystalline.
** Twice crystallized.
*** Crystallized three times.
Especially prepared and supplied to us through the courtesy of Mr. Charles C. Worth-
ington, of the Worthington Biochem. Corp., Freehold, New Jersey. The method of Smith
and Poiglase (3) was employed and hog mucosa preparations A, B, and C were tested.
b Prepared by us. See Reference 2.
o Supplied us through the courtesy of Dr. George M. Shadle, Parke Davis, Detroit,
Michigan.
d Supplied through the courtesy of Dr. Richard H. Barnes, Sharp and Dohme, West
Point, Pennsylvania.
Supplied through the courtesy of Dr. J. M. Ruegsegger, Lederle Laboratories Divi-
sion, Pearl River, New York.
All of the proteases employed were verified as to substrate specificity by
incubation with the following compounds (O.002M) *, and analysis of subsequent
paper chromatograms (phenol-water, ascending Whatman t' 1, ninhydrin spray)
(4):
Substrate Representing Enzyme
leucylglycylglycine aminopolypeptidase
carbobenzoxyglycyl-1-phenylalamine carboxypeptidase
carbobenzoxyglycyl-1-phenylalamine amide chymotrypsin
glycylglycine dipeptidase
benzoylglycine amide ficin
leucylglycine leucylpeptidase
benzoylarginine amide papain, with cysteine
carbobenzoxyl glutamyl-1-tryosine pepsin
benzoylarginine methylester HCL trypsin
RESULTS
Employing all of the different enzyme preparations listed above, it was found
that only members of the proteinase group were active as chemical excitants of
pruritus. Furthermore, only the endopeptidases with activities in the physiologic
pH range of 7 to 8 were effective. Exopeptidases, as well as endopeptidases with
an optimal pH below 4 (e.g., pepsin), were ineffective. The following list shows
the active agents:
Plant Animal
Bacterial proteinase Chymotrypsinf
Bromelin Pancreatin
Ficin Plasminf
Fungal proteinase Trypsinf
Mucunain
Papainf
* Obtained from Mann Research Lab., New York City.
t Crystalline enzymes used.
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Papain proved to be the most effective readily available crystalline protease
for study, and it was given by intradermal injection to 75 men. Each of them re-
ported a variable itching or burning itch appearingwithin 30 seconds. In all cases,
a variable degree of erythema and whealing could be found at the injection site.
It was noted that the dermal responses to the enzymes could be completely
eliminated by using the single trichome technic of introduction of the proteinase.
With this technic, which is practically an intra-epidermal injection, the sensation
of pruritus was produced, in the absence of any visible changes in the skin. Here
again the delay period was reduced to 4 or 5 seconds in experienced subjects. The
duration of the pruritus was variable, but with 1 % papain impregnated spicules
the sensation persisted as long as 30 minutes. With intradermal injections the
itch lasted about 2 to 5 minutes. The employment of th cantharidin vesicle
technic also reduced the delay period considerably so that pruritus was experi-
enced within 2 to 4 seconds after application of the enzyme solution. The duration
was from 3 to 8 minutes.
Papain was ineffective when diluted beyond a concentration of 1/10,000 and
the other proteinases showed critical dilutions below this level. Dilution invari-
ably diminished the intensity of the sensation experienced. The only sensations
experienced were itch and burning. Pain was never experienced even when the
strength of enzyme reached 1/100.
DISCUSSION
The most remarkable feature of these findings is the observation of pruritus
produced in the complete absence of visible or clinical changes in the skin. The
pruritus was sustained and severe and identical with that experienced by so many
dermatologic patients, both with and without skin lesions. It is apparent that the
introduction of free active proteolytic enzymes into the epidermis results in the
sensation of pruritus. Although histologic changes are undoubtedly occurring in
the epidermis, there are no grossly visible changes unless the enzyme is introduced
in larger amounts causing histamine release from the epidermis and dermis, with
subsequent urticaria (5).
The technic of intra-epidermal injection of appropriate enzyme concentration
has thus permitted us to dissociate the sensory epidermal response and the vascu-
lar dermal response. These findings of severe pruritus in the presence of grossly
normal skin strongly support the view that patients with the single sign of
generalized pruritus may be suffering from other than psychogenic pruritus.
With this demonstration that crystalline proteinases are a chemical stimulus
for pruritus, consideration was given to the role these enzymes may play in pro-
duction of clinical pruritus. There are two major sources of proteinase in the skin.
One is the epidermal cell itself which contains the proteinase group of cathepsins.
These are the intracellular endopeptidases of diverse types, but which have activi-
ties identical with those shown to produce pruritus experimentally (6). They are
difficult to release from the cell in active form, but several workers have demon-
strated the presence of proteinase in the human epidermis, using a potassium
chloride solution for extraction (7, 8, 9). The other known source of proteinase
is the circulating proteolytic enzyme system of the blood. All of these circulating
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enzymes are bound and inactive. The most carefully studied is plasminogen,
formerly labeled as profibrinolysin (10). Upon activation plasminogen becomes
plasmin which was shown experimentally to be an effective pruritogenic stimulus.
Thus we can perceive that clinical itching may well arise from the activation
and release of proteases in the region of the superficial epidermal nerve network
of receptors responsible for itch. It would appear that itching is a sensation
heralding epidermal skin damage, and that it arises not from physical stimuli but
rather from chemical stimuli, proteinase release being a central theme.
Ungar and his collaborators (11, 12) have presented valuable data concerning
the actual rise in proteolytic activity which occurs in allergic reactions, and in
response to histamine liberators. These are the verystatesinwhich pruritus occurs
clinically. Ungar and his group found that all antigen-antibody reactions within
cells were associated with a rapid activation and release of proteinases. Further-
more, morphine, tween 20, "48/80" and other histamine liberators caused not
only the appearance or release of histamine and heparin, but also the release of
proteinase activity. Ungar views the histamine liberators as general cytolytic
agents which do much more than release histamine.
It is now possible to postulate a common mode of action for the many divergent
clinical states and experimental procedures which lead to pruritus. All may be
assumed to show a common pattern of proteinase action. Thus, in allergic derma-
titis, anaphylactic shock, in various pruritic skin lesions, and in epidermal
damage, free proteinases or proteinase activators are released, resulting in itch.
The well known presence of proteinases in bacteria and fungi may correlate with
the pruritus seen at times clinically in bacterial and fungal infections of the epi-
dermis. Furthermore, mechanical and electrical stimuli which produce minor
epidermal cell injury may release or activate proteinases to produce the faint
temporary pruritus which is experienced.
From the chemical standpoint, a wide variety of urticariogenic compounds
cause pruritus. These are the histamine liberators (e.g., "48/80", proteinases,
salmine, stilbamidine, tween 20) (13, 14, 15, 16). Here, Ungar's work has shown
that these histamine liberators produce not only histamine release, but also a
concomitant appearance of active proteinase, as shown by proteolysis studies. It
is our view that this free proteinase either directly or indirectly activates epider-
mal sensory receptors resulting in pruritus.
There is little information regarding the mechanism of action of the endopep-
tidases in producing pruritus. The presence of the short but definite delay period
between the injection and sensation implies that some other process is occurring
and that the proteinase is probably not acting directly as a final chemical me-
diator. Again, the proteinase may be acting on the receptor organ or on the epi-
dermal cells, synthesizing or releasing an active compound.
The observation that histamine is pruritogenic (17), and that proteinases
release histamine might suggest that histamine itself is the chemical mediator
for itch. To test this hypothesis, spicules were impregnated with serial dilutions
of papain, histamine and 48/80.* It was found that papain spicules could be
* Supplied through the courtesy of E. J. deBeer of Welicome Research Laboratory,
Tuckahoe, New York.
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prepared to produce marked pruritus in the complete absence of clinical signs.
In contrast, both histamine and "48/80" spicules could never be made to dupli-
cate this. In fact, these spicules were markedly urticariogenic in dilutions that
were no longer pruritogenic. Finally, histamine itself never produces an instan-
taneous itching, but acts only after a delay period.
CONCLUSION
Endopeptidases of both plant and animal sources have been found to be a
uniquely effective chemical stimulus for the production of pruritus in man.
Introduced into the epidermis by a spicule technic they elicit a severe sustained
pruritus in the absence of any visible cutaneous change. It is postulated that the
release or activation of proteinases in the epidermis plays a significant role in
itching.
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